Your browser is no longer supported. Please, upgrade your browser.
Settings
CPIX Cumberland Pharmaceuticals Inc. daily Stock Chart
CPIX [NASD]
Cumberland Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.29 Insider Own40.40% Shs Outstand15.59M Perf Week-14.46%
Market Cap75.61M Forward P/E9.90 EPS next Y0.49 Insider Trans-1.38% Shs Float8.75M Perf Month-7.97%
Income-4.50M PEG- EPS next Q0.07 Inst Own31.90% Short Float1.01% Perf Quarter-10.35%
Sales45.50M P/S1.66 EPS this Y12.20% Inst Trans2.07% Short Ratio3.23 Perf Half Y-28.68%
Book/sh3.37 P/B1.44 EPS next Y22.50% ROA-4.40% Target Price12.25 Perf Year-22.40%
Cash/sh1.88 P/C2.58 EPS next 5Y30.00% ROE-8.80% 52W Range4.70 - 6.99 Perf YTD-19.57%
Dividend- P/FCF14.00 EPS past 5Y-31.20% ROI-9.80% 52W High-30.62% Beta0.12
Dividend %- Quick Ratio1.90 Sales past 5Y4.90% Gross Margin81.70% 52W Low3.19% ATR0.23
Employees80 Current Ratio2.30 Sales Q/Q22.40% Oper. Margin-10.60% RSI (14)35.27 Volatility4.26% 3.48%
OptionableNo Debt/Eq0.39 EPS Q/Q-20.50% Profit Margin-10.50% Rel Volume0.56 Prev Close4.98
ShortableYes LT Debt/Eq0.39 EarningsNov 12 AMC Payout- Avg Volume27.25K Price4.85
Recom- SMA20-10.84% SMA50-10.67% SMA200-15.58% Volume15,174 Change-2.61%
Nov-12-12Reiterated UBS Neutral $6.50 → $5
Feb-01-11Reiterated UBS Neutral $8 → $6.50
Dec-16-10Downgrade UBS Buy → Neutral $10 → $8
Aug-17-10Reiterated UBS Buy $11 → $10
Aug-17-10Reiterated Morgan Joseph Buy $15 → $10
Aug-17-10Downgrade Jefferies Buy → Hold $13 → $5.50
May-14-10Reiterated Morgan Joseph Buy $21 → $15
Nov-12-19 04:05PM  Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter PR Newswire
Nov-05-19 05:45PM  Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know Zacks
11:24AM  What's in Store for Cumberland Pharma (CPIX) in Q3 Earnings? Zacks
10:32AM  Cumberland Pharmaceuticals (CPIX) to Report Q3 Results: Wall Street Expects Earnings Growth Zacks
09:35AM  Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results PR Newswire
Nov-02-19 10:30AM  Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt? Simply Wall St.
Oct-30-19 05:45PM  Cumberland Pharmaceuticals (CPIX) Outpaces Stock Market Gains: What You Should Know Zacks
Oct-24-19 05:45PM  Cumberland Pharmaceuticals (CPIX) Stock Sinks As Market Gains: What You Should Know Zacks
Oct-16-19 05:50PM  Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know Zacks
Oct-15-19 09:35AM  New Study Reveals Superiority Of Vibativ® Over Vancomycin In Select Patients With Bacterial Pneumonia PR Newswire
Oct-10-19 05:45PM  Cumberland Pharmaceuticals (CPIX) Outpaces Stock Market Gains: What You Should Know Zacks
Oct-04-19 05:45PM  Cumberland Pharmaceuticals (CPIX) Stock Sinks As Market Gains: What You Should Know Zacks
Sep-26-19 11:01AM  New Strong Buy Stocks for September 26th Zacks +7.40%
Sep-25-19 12:25PM  Does Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) CEO Pay Matter? Simply Wall St.
Sep-24-19 09:35AM  Cumberland Pharmaceuticals Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program PR Newswire
Sep-19-19 08:01AM  New Strong Buy Stocks for September 19th Zacks +5.38%
Sep-13-19 09:25AM  Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy? Zacks
Sep-12-19 10:26AM  New Strong Buy Stocks for September 12th Zacks
09:00AM  Cumberland (CPIX) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
Sep-10-19 11:46AM  Theravance Announces Positive Early Data on JAK Inhibitor Zacks
Sep-09-19 09:50AM  New Strong Buy Stocks for September 9th Zacks +11.59%
Sep-06-19 10:33AM  Edited Transcript of CPIX earnings conference call or presentation 14-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
08:45AM  Here is Why Growth Investors Should Buy Cumberland (CPIX) Now Zacks
Sep-05-19 09:38AM  New Strong Buy Stocks for September 5th Zacks
Aug-21-19 08:45AM  Here is Why Growth Investors Should Buy Cumberland (CPIX) Now Zacks
Aug-14-19 05:25PM  Cumberland Pharmaceuticals (CPIX) Q2 Earnings Beat Estimates Zacks
04:05PM  Cumberland Pharmaceuticals Reports 14% Revenue Growth In The Second Quarter PR Newswire
07:24AM  Q2 Earnings Preview For Cumberland Benzinga
Aug-07-19 01:45PM  Cumberland Pharmaceuticals To Announce Second Quarter 2019 Financial Results PR Newswire
Aug-06-19 10:30AM  Cumberland Pharmaceuticals (CPIX) Earnings Expected to Grow: What to Know Ahead of Q2 Release Zacks
Jul-18-19 02:33PM  New antibiotics desperately needed for rising tide of drug-resistant superbugs American City Business Journals
Jul-12-19 02:30PM  When Will Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Turn A Profit? Simply Wall St.
Jul-05-19 10:09AM  Dova Pharmaceuticals (DOVA) in Focus: Stock Moves 9.1% Higher Zacks
Jun-26-19 08:32AM  Acer Shares Down on FDA's CRL for Genetic Disorder Treatment Zacks
Jun-25-19 05:50PM  Cumberland Pharmaceuticals (CPIX) Gains As Market Dips: What You Should Know Zacks
09:28AM  Why Taro Pharmaceutical (TARO) Could Be Positioned for a Slump Zacks
Jun-19-19 05:50PM  Cumberland Pharmaceuticals (CPIX) Stock Sinks As Market Gains: What You Should Know Zacks
08:25AM  The city's newest public company wants to build a new industry in Nashville American City Business Journals
Jun-18-19 10:25AM  Publicly traded San Diego firm moving HQ to Nashville American City Business Journals
Jun-04-19 10:08AM  The Zacks Analyst Blog Highlights: Flexible Solutions International, Qiwi, Cumberland Pharmaceuticals, CECO Environmental and Entravision Communications Zacks
09:30AM  Has Cumberland Pharmaceuticals (CPIX) Outpaced Other Medical Stocks This Year? Zacks
08:39AM  Nektar (NKTR) in Focus: Stock Moves 8.8% Higher Zacks
Jun-03-19 04:28PM  Edited Transcript of CPIX earnings conference call or presentation 14-May-19 8:30pm GMT Thomson Reuters StreetEvents
08:31AM  5 Stocks That Survived May's Market Mayhem Zacks
May-23-19 09:11AM  New Strong Buy Stocks for May 23rd Zacks
09:00AM  Cumberland (CPIX) Upgraded to Strong Buy: Here's What You Should Know Zacks
May-17-19 08:45AM  Is Cumberland (CPIX) a Solid Growth Stock? 3 Reasons to Think " Yes " Zacks +8.33%
May-15-19 09:35AM  Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China PR Newswire
May-14-19 05:45PM  Cumberland Pharmaceuticals (CPIX) Q1 Earnings and Revenues Beat Estimates Zacks
04:41PM  Cumberland: 1Q Earnings Snapshot Associated Press
04:05PM  Nashville health care company's strategic review leads it to China American City Business Journals
04:05PM  Cumberland Pharmaceuticals Reports 38% Revenue Growth In The First Quarter PR Newswire
May-08-19 05:45PM  Cumberland Pharmaceuticals (CPIX) Gains As Market Dips: What You Should Know Zacks
May-07-19 10:30AM  Analysts Estimate Cumberland Pharmaceuticals (CPIX) to Report a Decline in Earnings: What to Look Out for Zacks +7.23%
09:35AM  Cumberland Pharmaceuticals To Announce First Quarter 2019 Financial Results PR Newswire
07:53AM  What's in Cards for Cumberland (CPIX) This Earnings Season? Zacks
May-02-19 05:45PM  Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know Zacks
Apr-25-19 05:45PM  Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know Zacks
Apr-22-19 03:27PM  The Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Is Up 31% And Shareholders Are Holding On Simply Wall St.
Mar-29-19 10:42AM  Cumberland Pharmaceuticals Announces Strategic Review PR Newswire
Mar-12-19 07:48AM  Cumberland Pharmaceuticals Inc (CPIX) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-06-19 01:11PM  Is Cumberland Pharmaceuticals Inc.s (NASDAQ:CPIX) CEO Being Overpaid? Simply Wall St.
12:32AM  Edited Transcript of CPIX earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-26-19 04:05PM  Cumberland Pharmaceuticals Reports Fourth Quarter Revenue Growth Of 16% PR Newswire
02:30PM  Cumberland Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Feb-19-19 04:05PM  Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2018 Financial Results PR Newswire
Jan-30-19 07:44AM  The Boss: You can find Cumberland Pharmaceuticals' A.J. Kazimi courtside American City Business Journals
Jan-25-19 07:01AM  Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy? Zacks
Jan-23-19 08:47AM  With $500M in reserve, biotech cuts 49 jobs to focus on maturing drug pipeline American City Business Journals
Jan-11-19 10:32AM  Ocular (OCUL) Submits an sNDA for Eye Pain Drug Dextenza Zacks
Jan-03-19 10:26AM  Flexion Starts Phase III Enrollment on Zilretta for Hip OA Zacks -7.76%
Dec-19-18 03:09PM  Small Drug Stocks Near-Term Outlook Positive, Despite Headwinds Zacks +6.39%
Dec-11-18 02:26PM  Is Cumberland Pharmaceuticals Inc.s (NASDAQ:CPIX) Balance Sheet A Threat To Its Future? Simply Wall St.
Dec-03-18 08:46AM  U.S. and China set to finalize a trade deal in the next three months Yahoo Finance
Nov-14-18 07:21AM  Edited Transcript of CPIX earnings conference call or presentation 13-Nov-18 9:30pm GMT Thomson Reuters StreetEvents +12.00%
Nov-13-18 08:10PM  Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:01PM  Cumberland: 3Q Earnings Snapshot Associated Press
04:05PM  Cumberland Pharmaceuticals Reports Third Quarter 2018 Financial Results PR Newswire
Nov-07-18 04:05PM  Cumberland Pharmaceuticals To Announce Third Quarter 2018 Financial Results PR Newswire
Nov-06-18 02:23PM  Nashville pharma company pays $25M for drug brand American City Business Journals +16.01%
08:30AM  Theravance Biopharma Announces Sale of VIBATIV® (telavancin) to Cumberland Pharmaceuticals PR Newswire
08:30AM  Cumberland Pharmaceuticals To Acquire VIBATIV® PR Newswire
Sep-27-18 03:27PM  The Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Ownership Structure Could Be Important Simply Wall St.
09:00AM  Newly Published Data Demonstrates Amifostine Delayed The Onset Of Acute Esophagitis For Small Cell Lung Cancer Patients PR Newswire
Sep-24-18 10:00AM  Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors PR Newswire
Sep-21-18 12:18PM  Exclusive: Music industry giant joins public health care company's board American City Business Journals
Aug-30-18 05:51AM  Edited Transcript of CPIX earnings conference call or presentation 14-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-14-18 04:57PM  Cumberland: 2Q Earnings Snapshot Associated Press
04:05PM  Cumberland Pharmaceuticals Reports Second Quarter 2018 Financial Results PR Newswire
02:30PM  Cumberland Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Aug-13-18 10:00AM  Cumberland Pharmaceuticals Appoints New Senior Executive PR Newswire
Aug-07-18 04:05PM  Cumberland Pharmaceuticals To Announce Second Quarter 2018 Financial Results PR Newswire
Jun-08-18 11:48AM  What You Must Know About Cumberland Pharmaceuticals Incs (NASDAQ:CPIX) Financial Strength Simply Wall St.
Jun-05-18 05:58PM  Edited Transcript of CPIX earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-08-18 05:52PM  Cumberland: 1Q Earnings Snapshot Associated Press
04:05PM  Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results PR Newswire
May-01-18 09:35AM  Cumberland Pharmaceuticals To Announce First Quarter 2018 Financial Results PR Newswire
Apr-09-18 09:00AM  Cumberland Pharmaceuticals Expands into Oncology Support PR Newswire
Mar-29-18 11:59AM  Why Cumberland Pharmaceuticals Incs (NASDAQ:CPIX) Ownership Structure Is Important Simply Wall St.
Mar-26-18 09:35AM  Newly Published Data Demonstrates 85% Eradication of Ulcer Causing Bacteria PR Newswire
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology markets in the United States and internationally. It offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating hyponatremia; Ethyol injection for the reduction of xerostomia; Totect injection, for emergency oncology intervention, to treat the toxic effects of anthracycline chemotherapy; and Vibativ injection, for the treatment of certain serious bacterial infections. The company's Phase II product candidates includes Hepatoren injection for the treatment of critically ill patients suffering from liver and kidney failure; Boxaban oral capsules for the treatment of asthma patients; Vasculan oral capsule for the treatment of systemic sclerosis; and Portaban for the treatment of portal hypertension. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as severe disabling psoriasis. The company markets and sells its products through sales representatives and district managers. Cumberland Pharmaceuticals Inc. has a strategic alliance with Clinigen Group plc and Nordic Group B.V. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young CarolineDirectorOct 20Buy5.4614767,268Oct 25 05:15 PM
Krogulski KennethDirectorOct 19Buy5.5138209165,495Oct 25 05:14 PM
Galante Joseph CDirectorOct 18Buy5.453418516,692Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 18Buy5.45341855,767,616Oct 25 05:13 PM
Krogulski KennethDirectorOct 18Buy5.4565354165,457Oct 25 05:14 PM
Young CarolineDirectorOct 18Buy5.48502747,254Oct 25 05:15 PM
Galante Joseph CDirectorOct 17Buy5.526033116,658Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 17Buy5.52603315,767,582Oct 25 05:13 PM
Krogulski KennethDirectorOct 17Buy5.5265359165,392Oct 25 05:14 PM
Galante Joseph CDirectorOct 16Buy5.566033416,598Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 16Buy5.56603345,767,522Oct 25 05:13 PM
Krogulski KennethDirectorOct 16Buy5.5665361165,327Oct 25 05:14 PM
Young CarolineDirectorOct 16Buy5.54502777,204Oct 25 05:15 PM
Galante Joseph CDirectorOct 15Buy5.636033816,538Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 15Buy5.63603385,767,462Oct 25 05:13 PM
Krogulski KennethDirectorOct 15Buy5.6365366165,262Oct 25 05:14 PM
Galante Joseph CDirectorOct 14Buy5.676034016,478Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 14Buy5.67603405,767,402Oct 25 05:13 PM
Krogulski KennethDirectorOct 14Buy5.6765369165,197Oct 25 05:14 PM
Young CarolineDirectorOct 14Buy5.65502837,154Oct 25 05:15 PM
Galante Joseph CDirectorOct 11Buy5.716034316,418Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 11Buy5.71603435,767,342Oct 25 05:13 PM
Krogulski KennethDirectorOct 11Buy5.7165371165,132Oct 25 05:14 PM
Galante Joseph CDirectorOct 10Buy5.866035216,358Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 10Buy5.86603525,767,282Oct 25 05:13 PM
Krogulski KennethDirectorOct 10Buy5.8665381165,067Oct 25 05:14 PM
Young CarolineDirectorOct 10Buy5.78502897,104Oct 25 05:15 PM
Galante Joseph CDirectorOct 09Buy5.786034716,298Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 09Buy5.78603475,767,222Oct 25 05:13 PM
Krogulski KennethDirectorOct 09Buy5.7865376165,002Oct 25 05:14 PM
Galante Joseph CDirectorOct 08Buy5.816034916,238Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 08Buy5.81603495,767,162Oct 25 05:13 PM
Krogulski KennethDirectorOct 08Buy5.8165378164,937Oct 25 05:14 PM
Young CarolineDirectorOct 08Buy5.79502907,054Oct 25 05:15 PM
Galante Joseph CDirectorOct 07Buy5.746034416,178Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 07Buy5.74603445,767,102Oct 25 05:13 PM
Krogulski KennethDirectorOct 07Buy5.7465373164,872Oct 25 05:14 PM
Galante Joseph CDirectorOct 04Buy5.766034616,118Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 04Buy5.76603465,767,042Oct 25 05:13 PM
Krogulski KennethDirectorOct 04Buy5.7665374164,807Oct 25 05:14 PM
Young CarolineDirectorOct 04Buy5.75502887,004Oct 25 05:15 PM
Galante Joseph CDirectorOct 02Buy5.776034616,058Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 02Buy5.77603465,766,982Oct 25 05:13 PM
Krogulski KennethDirectorOct 02Buy5.7765375164,742Oct 25 05:14 PM
Galante Joseph CDirectorOct 01Buy5.896035315,998Oct 25 05:12 PM
KAZIMI A JChairman and CEOOct 01Buy5.89603535,766,922Oct 25 05:13 PM
Krogulski KennethDirectorOct 01Buy5.8965383164,677Oct 25 05:14 PM
Young CarolineDirectorOct 01Buy5.83502926,954Oct 25 05:15 PM
Galante Joseph CDirectorSep 30Buy5.896035315,938Oct 25 05:12 PM
KAZIMI A JChairman and CEOSep 30Buy5.89603535,766,862Oct 25 05:13 PM
Krogulski KennethDirectorSep 30Buy5.8965383164,612Oct 25 05:14 PM
Galante Joseph CDirectorSep 27Buy5.766034615,878Oct 25 05:12 PM
KAZIMI A JChairman and CEOSep 27Buy5.76603465,766,802Oct 25 05:13 PM
Krogulski KennethDirectorSep 27Buy5.7665374164,547Oct 25 05:14 PM
Galante Joseph CDirectorSep 26Buy5.766034615,818Oct 25 05:12 PM
KAZIMI A JChairman and CEOSep 26Buy5.76603465,766,742Oct 25 05:13 PM
Krogulski KennethDirectorSep 26Buy5.7665374164,482Oct 25 05:14 PM
Young CarolineDirectorSep 26Buy5.81754366,904Oct 25 05:15 PM
Galante Joseph CDirectorSep 25Buy5.386032315,758Oct 25 05:12 PM
KAZIMI A JChairman and CEOSep 25Buy5.38603235,766,682Oct 25 05:13 PM
Krogulski KennethDirectorSep 25Buy5.3865350164,417Oct 25 05:14 PM
Bernard Gordon RDirectorSep 25Sale5.313,47018,4261,000Sep 27 05:18 PM
Galante Joseph CDirectorSep 24Buy5.396032315,698Oct 25 05:12 PM
KAZIMI A JChairman and CEOSep 24Buy5.39603235,766,622Oct 25 05:13 PM
Krogulski KennethDirectorSep 24Buy5.3965350164,352Oct 25 05:14 PM
Galante Joseph CDirectorSep 23Buy5.356032115,638Oct 25 05:12 PM
KAZIMI A JChairman and CEOSep 23Buy5.35603215,766,562Oct 25 05:13 PM
Krogulski KennethDirectorSep 23Buy5.3565348164,287Oct 25 05:14 PM
Young CarolineDirectorSep 23Buy5.37754036,829Oct 25 05:15 PM
Bernard Gordon RDirectorSep 23Sale5.274,40023,1884,470Sep 27 05:18 PM
Galante Joseph CDirectorSep 20Buy5.336032015,578Oct 25 05:12 PM
KAZIMI A JChairman and CEOSep 20Buy5.33603205,766,502Oct 25 05:13 PM
Krogulski KennethDirectorSep 20Buy5.3365346161,422Oct 25 05:14 PM
Bernard Gordon RDirectorSep 20Sale5.313,70019,6478,870Sep 27 05:18 PM
Krogulski KennethDirectorSep 19Buy5.2165339164,157Sep 20 05:18 PM
Galante Joseph CDirectorSep 19Buy5.216031315,518Sep 20 05:17 PM
KAZIMI A JChairman and CEOSep 19Buy5.21603135,766,442Sep 20 05:16 PM
Bernard Gordon RDirectorSep 19Sale5.214,00020,84012,170Sep 20 05:16 PM
Krogulski KennethDirectorSep 18Buy4.93130641164,092Sep 20 05:18 PM
Galante Joseph CDirectorSep 18Buy4.9312059215,458Sep 20 05:17 PM
Young CarolineDirectorSep 18Buy5.15753866,754Oct 25 05:15 PM
KAZIMI A JChairman and CEOSep 18Buy4.931205925,766,382Sep 20 05:16 PM
Bernard Gordon RDirectorSep 18Sale4.952,98714,78616,170Sep 20 05:16 PM
Bernard Gordon RDirectorSep 17Sale4.917113,49119,157Sep 20 05:16 PM
Krogulski KennethDirectorSep 16Buy4.9765323163,962Sep 20 05:18 PM
Galante Joseph CDirectorSep 16Buy4.976029815,338Sep 20 05:17 PM
KAZIMI A JChairman and CEOSep 16Buy4.97602985,766,262Sep 20 05:16 PM
Bernard Gordon RDirectorSep 16Sale5.0510050519,868Sep 20 05:16 PM
Krogulski KennethDirectorSep 13Buy5.18130673163,897Sep 20 05:18 PM
Galante Joseph CDirectorSep 13Buy5.1812062215,278Sep 20 05:17 PM
Young CarolineDirectorSep 13Buy5.03753776,679Oct 25 05:15 PM
KAZIMI A JChairman and CEOSep 13Buy5.181206225,766,202Sep 20 05:16 PM
Bernard Gordon RDirectorSep 13Sale5.113,11715,92819,968Sep 20 05:16 PM
Bernard Gordon RDirectorSep 12Sale5.152,64613,62723,085Sep 13 05:27 PM
Krogulski KennethDirectorSep 11Buy5.0265326163,767Sep 20 05:18 PM
Galante Joseph CDirectorSep 11Buy5.026030115,158Sep 20 05:17 PM
KAZIMI A JChairman and CEOSep 11Buy5.02603015,766,082Sep 20 05:16 PM
Bernard Gordon RDirectorSep 11Sale5.012,70013,52725,731Sep 13 05:27 PM
Krogulski KennethDirectorSep 10Buy5.3865350163,702Sep 20 05:18 PM
Galante Joseph CDirectorSep 10Buy5.386032315,098Sep 20 05:17 PM